Figure 7.
Construction and evaluation of a nomogram prognosis model in the TCGA cohort. (A) Nomogram based on DLFscore and clinicopathological factors for 1-, 3- and 5-year disease-free survival prediction of prostate cancer patients. (B) Evolution of the prognostic nomogram model for 1-, 3- and 5-year disease-free survival prediction. (C) ROC curve of 1-, 3- and 5-year disease-free survival prediction for the prognostic nomogram model. TCGA, The cancer genome atlas; DLFscore, deep learning-based ferroptosis score; ROC, receiver operating characteristic; AUC, area under the curve; PSA, prostate-specific antigen.